BTZ043

Name: BTZ043
Brand: SIGMA

≥98% (HPLC)

别名:

2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-Benzothiazin-4-one; (S)-2-(2-Methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one, 2-[(3S)-3-Methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₇H₁₆F₃N₃O₅S

化学文摘社编号:

1161233-85-7

分子量:

431.39

Assay:

≥98% (HPLC)

Form:

powder

Quality level:

100

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

100

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

说明

Biochem/physiol Actions

BTZ043 is the first in a new class of antibiotics that kills all clinically relevant strains of Mycobacterium Tuberculosis, including multi-drug resistant strains, with minimal inhibitory concentrations (MIC) in the ng/ml range (MIC = 2.3 nM against M. tuberculosis H37Rv and 9.2 nM against M. smegmatis). BTZ043 potently inhibits the enzyme decaprenylphosphoryl-β-D-ribose 2’-epimerase (DprE1), which is essential for the formation of decaprenylphosphoryl arabinose, a key component in cell wall synthesis. It appears that BTZ-043 diffuses and accumulates in centrally necrotizing granulomas (necrotic lesions) harboring Mycobacterium tuberculosis.